Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Nevan C. Elam currently holds 605,497 shares of NEKTAR THERAPEUTICS (NKTR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nevan C. Elam has been a net seller of NKTR stock. They have purchased $59.3K and sold $442.0K worth of shares.
Nevan C. Elam's most recent insider trade was on Jul 2, 2026, when they sold 8,004 shares at $4.99 per share.
Nevan C. Elam serves as Executive at NEKTAR THERAPEUTICS (NKTR). They have executed 23 insider transactions totaling $501.3K over their tenure at the company.
Nevan C. Elam holds the position of Executive at NEKTAR THERAPEUTICS, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Nevan C. Elam has shown a selling trading pattern, with $59.3K in total purchases and $442.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Nevan C. Elam was on Dec 28, 2023, when they sold $442.0K worth of SVRA shares. This transaction involved 93,843 shares at $4.71 per share.
Nevan C. Elam currently owns 605,497 shares of NEKTAR THERAPEUTICS (NKTR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Nevan C. Elam's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Nevan C. Elam has 23 Form 4 filings on record as an insider at NEKTAR THERAPEUTICS.
Set alerts for Nevan C. Elam and 40,000+ other insiders.